|
Issue 1267: September 28, 2016
Ask the Experts—Question of the Week: Is it acceptable to write the
expiration date (the “Beyond Use Date”) of an opened…read more
TOP STORIES
IAC HANDOUTS
VACCINE INFORMATION STATEMENTS
FEATURED RESOURCES
JOURNAL ARTICLES AND NEWSLETTERS
EDUCATION AND TRAINING
TOP STORIES
IAC Spotlight! IAC enrolls ten new birthing institutions into its Hepatitis B Birth Dose Honor Roll; two previously honored institutions qualify for additional periods
The Immunization Action Coalition (IAC) is pleased to announce that ten new institutions have been accepted into its Hepatitis B Birth Dose Honor Roll. The birthing institutions are listed below with their reported hepatitis B birth dose coverage rates in parentheses.
- Baylor, Scott & White Medical Center–Lake Pointe, Rowlett, TX (93%)
- Claxton-Hepburn Medical Center, Ogdensburg, NY (95%)
- Delaware County Memorial Hospital, Drexel Hill, PA (98%)
- Families Are First Birthing Center Bristol Hospital, Bristol, CT (99%)
- Griffin Hospital, Derby, CT (95%)
- Holy Cross Hospital, Nogales, AZ (98%)
- Johnson Memorial Hospital, Franklin, IN (100%)
- Maine Medical Center/Barbara Bush Children’s Hospital, Portland, ME
(90%)
- Wadley Regional Medical Center, Texarkana, TX (95%)
- Warren General Hospital, Warren, PA (99%)
The following institution is being recognized for a second year:
- Brooks Memorial Hospital, Dunkirk, NY (93%)
Finally, the following institution is being recognized for a third year:
- Palo Pinto General Hospital, Mineral Wells, TX (97%)
The Honor Roll now includes 289 birthing institutions from 38 states, Puerto Rico, and Guam. Eighty-three institutions have qualified for two years, 26 institutions have qualified three times, one institution has qualified four times, and one institution has qualified five times.
The Honor Roll is a key part of IAC’s major initiative urging the nation’s
hospitals to Give birth to the end of Hep B. Hospitals and birthing centers are recognized for attaining high coverage rates for administering hepatitis B vaccine at birth and meeting specific additional criteria. The initiative urges qualifying healthcare organizations to apply for the Hepatitis B Birth Dose Honor Roll online.
To be included in the Hepatitis B Birth Dose Honor Roll, a birthing institution must have: (1) reported a coverage rate of 90 percent or greater, over a 12-month period, for administering hepatitis B vaccine before hospital discharge to all newborns, including those whose parents refuse vaccination, and (2) implemented specific written policies, procedures, and protocols to protect all newborns from hepatitis B virus infection prior to hospital discharge.
Honorees are also awarded an 8.5" x 11" color certificate suitable for framing and their acceptance is announced to
IAC Express’s approximately 50,000 readers.
Please visit the Hepatitis B Birth Dose Honor Roll web page that lists these institutions and their exceptional efforts to protect infants from perinatal hepatitis B transmission.
Related Links
Back to top
CDC reports on death of a toddler from meningococcal disease in MMWR
CDC published Notes from the Field:
Pediatric Death from Meningococcal Disease in a Family of Romani
Travelers—Sarasota, Florida, 2015 in the September 23 issue of MMWR (page 1017). An excerpt from the article is reprinted below.
On January 31, 2015, the Sarasota County Office of the Medical Examiner
notified the on-call epidemiologist at the Florida Department of Health, Bureau
of Epidemiology of a possible death from meningococcal disease in a male child
aged 17 months. The child was part of a large non–English-speaking Romani family
(whose members self-identified as Gypsies), who arrived in Florida after
traveling in Texas and Europe during the previous 2 months. The child had no
history of prior meningococcal immunization. The family reported that the child
had been sick for at least 7 days with an ear infection; however, this diagnosis
was not confirmed by a physician. Because of increasing fever and onset of
vomiting, emergency medical service (EMS) staff members were contacted and the
child was transported to a local emergency department on January 29, 2015.
Although he was reportedly interactive and alert during registration, he
developed a rash while in the emergency department, his condition rapidly
deteriorated, and he died within four hours. An autopsy was performed on January
30, and on January 31, the medical examiner reported Gram-negative diplococci in
the cerebrospinal fluid (CSF).
Related Links
Back to top
CDC and NFID to host a Thunderclap for flu prevention on September 29
CDC and NFID will host a Thunderclap that will go live on September 29 at 10:00 a.m. (ET) in conjunction with the seasonal flu kick-off. At the Thunderclap page, choose one of the red buttons to select which channel you want to use to support the campaign and authorize Thunderclap to use your account. Then watch #FightFlu on September 29 as Thunderclap supporters proclaim to #FightFlu together! Same tweets and status are available on the campaign web page.
Thunderclap is a social media tool that allows supporters to sign up in advance
to share a unified message at a specific time via their individual social media
accounts. The collective action creates a wave of support—or
“thunderclap”—across social media.
Back to top
Medscape posts video about CDC's influenza vaccine recommendations for 2016–2017
season
Medscape recently posted
CDC Provides Vaccine Recommendations for the 2016–2017 Influenza Season. The resource provides an overview of products and recommendations available for this season. There is no cost to view the report on Medscape, but you must register.
Back to top
IAC HANDOUTS
IAC posts revised “Vaccines with Diluents: How to Use Them”
IAC recently posted Vaccines with Diluents: How to Use Them.
The resource was updated to reflect the new acceptable temperatures for
refrigerated products of 36–46 degrees Fahrenheit.
Related Links
Back to top
IAC updates “Hepatitis A & B Vaccines: Be Sure Your Patients Get the Correct
Dose!”
IAC recently posted an updated version of Hepatitis A & B Vaccines: Be Sure Your Patients Get the Correct Dose! Changes were made to remove the column that displayed the units of vaccine antigen that were to be administered, while retaining volume as a more meaningful measurement.
Find all recently updated resources on What's New at IAC at immunize.org.
Back to top
IAC posts revised “Handy Resources,” a handout about IAC's free publications
IAC recently posted an updated promotional flyer titled Handy Resources. This handout is an easy way to get people connected to IAC's top publication and website resources.
IAC's Handouts for Patients & Staff web section offers healthcare professionals and the public more than 250 FREE English-language handouts (many also available in translation), which we encourage website users to print out, copy, and distribute widely.
Back to top
VACCINE INFORMATION STATEMENTS
IAC posts four translations of the Haemophilus influenzae type b (Hib) VIS
IAC recently posted the following translations of the Haemophilus influenzae type b (Hib) VIS, dated 4/2/2015:
Related Links
Back to top
IAC posts three translations of the Meningococcal (MCV4/MPSV4) VIS
IAC recently posted the following translations of the Meningococcal (MCV4/MPSV4) VIS, dated 3/31/2016:
Related Links
Back to top
IAC posts four translations of the Pneumococcal Conjugate (PCV13) VIS
IAC recently posted the following translations of the Pneumococcal Conjugate (PCV13) VIS, dated 11/5/2015:
Related Links
Back to top
IAC posts eight translations of the Td VIS
IAC recently posted the following translations of the Td VIS, dated 2/24/2015:
Related Links
Back to top
Download Dr. Gary Marshall's The Vaccine Handbook: A Practical Guide for Clinicians
(“The Purple Book") as an app for iOS devices or purchase as a print book
The Vaccine Handbook: A Practical Guide for Clinicians (“The Purple
Book,” 2015) is a comprehensive source of practical, up-to-date information
for vaccine providers and educators. Its author, Gary S. Marshall, MD, has
drawn together the latest vaccine science and guidance into a concise,
user-friendly, practical resource for the private office, public health
clinic, academic medical center, and hospital. This book is now available as
an app for iOS devices.
Information about the iOS app version of The Vaccine Handbook: A Practical Guide for Clinicians
The Vaccine Handbook App contains the 5th edition of the book, updated with the latest immunization schedules and recommendations. The app enhances the utility of an already valuable print resource by including functions like keyword search, internal links, bookmarking, quick access to schedules and tables, hyperlinks to external sources, and the ability for real-time updates. A resources section provides ready access to authoritative immunization-related websites. Available through a collaboration between the publisher and Sanofi Pasteur, registration as well as reporting under Open Payments is required. (Offer void in Minnesota.) Click on the image below to visit the relevant App Store page to download this resource today.
Information about the print version of The Vaccine Handbook: A Practical Guide for Clinicians
The fifth edition of this valuable guide (560 pages) is available on IAC's website at www.immunize.org/vaccine-handbook. The price of the handbook is $29.95 each, plus shipping charges. Discount pricing is available for more than 10 copies. Order copies for your staff or for distribution at an upcoming conference.
Quantity Discount Pricing
- 1–10 books: no discount + shipping
- 11–50 books: 5% + shipping
- 51–100 books: 10% + shipping
- 101–500 books: 15% + shipping
- 501–1000 books: 20% + shipping
For quotes on larger quantities, email admininfo@immunize.org.
Order your copy today! Click on the image below to visit the "Shop IAC: The Vaccine Handbook" web page.
About the Author
Gary Marshall, MD, is professor of pediatrics at the University of Louisville School of Medicine in Kentucky, where he serves as chief of the division of pediatric infectious diseases and director of the Pediatric Clinical Trials Unit. In addition to being a busy clinician, he is nationally known for his work in the areas of vaccine research, advocacy, and education.
Related Link
Back to top
JOURNAL ARTICLES AND NEWSLETTERS
The Lancet publishes article about trends in vaccine coverage
The Lancet recently published Global trends in vaccination coverage. The "Summary" section is reprinted below.
Universal vaccination programmes have greatly reduced the burden of infectious diseases in both developing and developed countries. In the 1960s and 1970s, these reductions led to optimism that a victory in the battle against infectious diseases could be within reach. Unfortunately, even though the benefits of most childhood vaccinations are scientifically unquestioned, vaccination coverage rates are far from 100% in many countries, and show substantial variation. Early detection of trends and an improved understanding of underlying mechanisms are paramount to be able to improve vaccination policies.
Related Links
Back to top
CDC reports about influenza activity in the United States from May 22 to September 10, 2016
CDC published
Update: Influenza Activity—United States and Worldwide, May 22–September 10,
2016 in the September 23 issue of MMWR
(pages 1008–1014). A summary made available to the press is reprinted below.
The U.S. experienced typical low levels of seasonal influenza activity
overall from May 22 to September 10, 2016; however, since late August, CDC
received reports of a small number of localized influenza A (H3N2) outbreaks.
Influenza A (H1N1) pdm09, influenza A (H3N2), and influenza B viruses were
detected during May–September worldwide and in the U.S. It is not possible to
predict which influenza virus strains will predominate nor the timing or
severity of the 2016–17 season. It is also not possible to predict how effective
influenza vaccine will be this season because many factors can influence
effectiveness. However, CDC does not anticipate the low level of vaccine
effectiveness caused by antigenic drift that was seen during the 2014–15 influenza season; this is because most of the circulating viruses characterized in CDC laboratories since February 2016 do not show significant antigenic changes.
Back to top
EDUCATION AND TRAINING
Hepatitis B Foundation and AAPCHO to present “Bring it Home! Strategies to
Work with Your Local Policymakers on Hepatitis B” webinar on September 29
In the United States, up to 2.2 million Americans are living with chronic hepatitis B, a disease that is silent and largely undiagnosed. It is important that advocates, including community organizations, health professionals, and individuals, know about current issues impacting hepatitis B policy and educate their policymakers about hepatitis B-related health disparities.
Join the Hepatitis B Foundation and Association of Asian Pacific Community Health Organizations on September 29, beginning at 2:00 p.m. (CT), for an interactive session about advocacy strategies at the city and state levels on policies that impact hepatitis B, including best practices from New York City's hepatitis B advocacy initiatives. Registration is required.
Back to top
NFID to offer webinar, “Influenza Prevention in U.S. Adults Age 65 Years and
Older,” on October 5
The National Foundation for Infectious Diseases (NFID) will present a one-hour webinar, beginning at 12:00 p.m. (ET) on October 5. Titled Influenza Prevention in U.S. Adults Age 65 Years and Older, the webinar will feature William Schaffner, MD, medical director, NFID; H. Keipp Talbot, MD, MPH, assistant professor of Medicine at Vanderbilt University School of Medicine; and Robert H. Hopkins, Jr., MD, professor of Internal Medicine and Pediatrics and director of the Division of General Internal Medicine at the University of Arkansas for Medical Sciences.
Registration (required) is open now.
Related Link
Back to top
CDC updates its "You Call the Shots" module on varicella; free CE credit available
CDC recently updated the varicella module of its web-based training course You Call the Shots. The nurse education training program has 11 modules on a variety of immunization topics (e.g., DTaP, Hepatitis A, Influenza, Vaccine Storage and Handling, Vaccines for Children). Continuing education credit is available for viewing a module and completing an evaluation. The training course is supported by CDC through a cooperative agreement with the Association for Prevention Teaching and Research.
The varicella module was updated in September. Participants can access information about obtaining CE credit from the You Call the Shots main page.
Related Links
Back to top
ASK THE EXPERTS
Question of the Week
Is it acceptable to write the expiration date (the “Beyond Use Date”) of
an opened vaccine multi-dose vial on the box rather than the vial or must it be
written on the vial?
It is acceptable to put the Beyond Use Date (BUD) on the packaging; this may help when reviewing inventory. But a provider should always read the label on the vial before administering a vaccine. It is possible for a vial to be placed in the wrong box. So the vial label is the safest place to put the BUD. Vial labels are small and it may require putting an extra sticky label on the vial.
About IAC's Question of the Week
Each week, IAC Express highlights a new, topical, or
important-to-reiterate Q&A. This feature is a cooperative venture between IAC
and CDC. William L. Atkinson, MD, MPH, IAC's associate director for immunization
education, chooses a new Q&A to feature every week from a set of Q&As prepared
by experts at CDC’s National Center for Immunization and Respiratory Diseases.
We hope you enjoy this feature and find it helpful when dealing with difficult real-life scenarios in your vaccination practice. Please encourage your healthcare professional colleagues to sign up to receive IAC Express at www.immunize.org/subscribe.
If you have a question for the CDC immunization experts, you can email them directly at nipinfo@cdc.gov. There is no charge for this service.
Related Links
Back to top
|
